Terms: = Sarcomas AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
419 results:
1. The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.
Korbecki J; Bosiacki M; Szatkowska I; Kupnicka P; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673949
[TBL] [Abstract] [Full Text] [Related]
2. The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.
Das J; Bera S; Ganguly N; Guha I; Ghosh Halder T; Bhuniya A; Nandi P; Chakravarti M; Dhar S; Sarkar A; Das T; Banerjee S; Ghose S; Bose A; Baral R
Front Immunol; 2024; 15():1325161. PubMed ID: 38585261
[TBL] [Abstract] [Full Text] [Related]
3. Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.
Bhushan B; Iranpour R; Eshtiaghi A; da Silva Rosa SC; Lindsey BW; Gordon JW; Ghavami S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474036
[TBL] [Abstract] [Full Text] [Related]
4. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of anlotinib-induced autophagy attenuates invasion and migration by regulating epithelial-mesenchymal transition and cytoskeletal rearrangement through ATG5 in human osteosarcoma cells.
Zheng B; Sun X; Zhang L; Qu G; Ren C; Yan P; Zhou C; Yue B
Braz J Med Biol Res; 2024; 57():e13152. PubMed ID: 38381883
[TBL] [Abstract] [Full Text] [Related]
6. Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions.
Rosell R; Pedraz-Valdunciel C; Jain A; Shivamallu C; Aguilar A
Expert Opin Investig Drugs; 2024 Mar; 33(3):171-182. PubMed ID: 38372666
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
8. Spindle and kinetochore-related complex subunit 3 has a protumour function in osteosarcoma by activating the Notch pathway.
Liang G; Duan C; He J; Shi L
Toxicol Appl Pharmacol; 2024 Feb; 483():116826. PubMed ID: 38228236
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract] [Full Text] [Related]
10. Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway.
Wang L; Piao L; Yuan X; Tong L; Han X; Wang J; Shi D; Shao S; Xu X; Zhuang M; Cheng D; Liu Z
Ann Clin Lab Sci; 2023 Nov; 53(6):890-904. PubMed ID: 38182149
[TBL] [Abstract] [Full Text] [Related]
11. Epithelial to mesenchymal transition (emt) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract] [Full Text] [Related]
12. Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
13. Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of sarcomas.
Daniel AR; Su C; Williams NT; Li Z; Huang J; Lopez O; Luo L; Ma Y; Campos LDS; Selitsky SR; Modliszewski JL; Liu S; Hernansaiz-Ballesteros R; Mowery YM; Cardona DM; Lee CL; Kirsch DG
Cancer Res Commun; 2023 Dec; 3(12):2455-2467. PubMed ID: 37982576
[TBL] [Abstract] [Full Text] [Related]
14. INHBA gene silencing inhibits proliferation, migration, and invasion of osteosarcoma cells by repressing TGF-β signaling pathway activation.
Zhang H; Huang Y; Wen Q; Li Y; Guo L; Ge N
J Orthop Surg Res; 2023 Nov; 18(1):848. PubMed ID: 37940978
[TBL] [Abstract] [Full Text] [Related]
15. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract] [Full Text] [Related]
16. [Identification of epithelial-mesenchymal transition markers (emt) by immunohistochemistry in pediatric osteosarcoma and association with clinical outcomes].
Fonseca EV; Olaya N; Patifto EF; Aponte NH; Linares Ballesteros A
Andes Pediatr; 2022 Dec; 93(6):868-877. PubMed ID: 37906804
[TBL] [Abstract] [Full Text] [Related]
17. LINC01094 promotes human nasal epithelial cell epithelial-to-mesenchymal transition and pyroptosis via upregulating HMGB1.
Liu Z; Fu Y; Huang W; Li C; Wei X; Zhan J; Zheng J
Rhinology; 2024 Feb; 62(1):88-100. PubMed ID: 37864411
[TBL] [Abstract] [Full Text] [Related]
18. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptional regulation of emt transcription factors in cancer.
Saitoh M
Semin Cancer Biol; 2023 Dec; 97():21-29. PubMed ID: 37802266
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding HOXA-AS3 contributes to osteosarcoma progression through the miR-1286/TEAD1 axis.
Xiao X; Liu M; Xie S; Liu C; Huang X; Huang X
J Orthop Surg Res; 2023 Sep; 18(1):730. PubMed ID: 37752588
[TBL] [Abstract] [Full Text] [Related]
[Next]
